Cover Image

Novo Nordisk surges to success, but will it survive unscathed? /

Novo Nordisk, a pharmaceutical company based in Denmark, has boosted its home country's financial state thanks to its widely publicized weight loss drugs, Wegovy and Ozempic. While consumer response to the medicines has been overwhelming, it remains to be seen whether the company can sustain it...

Full description

Bibliographic Details
Main Author: Mehta, Simran (Author)
Format: eBook
Language:English
Published: London : SAGE Publications: SAGE Business Cases Originals, 2023.
Series:SAGE business cases.
Subjects:
Novo Nordisk > Management > Case studies.
Pharmaceutical industry > Denmark > Case studies.
Denmark > Economic conditions > Case studies.
Industrie pharmaceutique > Danemark > Études de cas.
Danemark > Conditions économiques > Études de cas.
Economic history
Management
Pharmaceutical industry
Denmark
Electronic books.
Case studies
Online Access:Connect to the full text of this electronic book
Description
Summary:Novo Nordisk, a pharmaceutical company based in Denmark, has boosted its home country's financial state thanks to its widely publicized weight loss drugs, Wegovy and Ozempic. While consumer response to the medicines has been overwhelming, it remains to be seen whether the company can sustain its massive growth in the long term. This case study examines how Novo Nordisk could impact not only the pharmaceutical world but also Denmark's overall economy.
Physical Description:1 online resource : illustrations.
ISBN:9781071940945
1071940945